Researchers formulate a urine-based kidney cancer detection solution


Research teams Mintota and Photochemistry Reactivity Group, a part of the faculties of Chemistry and Pharmacy, University of Valencia have reportedly developed a solution to detect kidney cancer through urine along with the dispersion of gold nanoparticles.

Notably, the novel system is the first technology to offer reliable information regarding the existence and progress of the novel pathology.

Citing reliable sources, the patent has been registered by the University of Valencia along with the participation of FISABIO -the Foundation for the Promotion of the Sanitary and Biomedical investigation of the Valencian Community and the Health Research Institute Hospital La Fe.

As per a report by the World Health Organization, cancer has emerged as the second-largest reason for death, globally. Almost ten million people die each year from this disease. In Spain alone, the total death cases linked to cancer are up to 400,000, and the cases of kidney cancer range between 2% to 3% of the total population.

Pilar Campis Falco, Director of Mintota Research Group and Professor at the Faculty of Chemistry, indicated that there is a surging need for effective methods that help in early diagnosis and appropriate follow-up of patients, and must be cost-effective and applicable to easily gain biological samples like urine.

Elaborating on the need for an advanced diagnosis mechanism, Julia Pérez Prieto, Director of the University's Photochemical Reactivity Group of Valencia, and Professor at the Faculty of Pharmacy, mentioned that urine is a relatively less complex solution and a more manageable measure to detect the presence of biomarkers of a malignant tumor.    

It is worth mentioning that the patented method is an effective, simple, and non-invasive diagnostic tool which can also be used as a test at the point-of-care level, which is the diagnoses at a point of care close to patients with rapid and reliable results.

Source Credits: